The Ovarian Cancer Clinical Aspects and at least Two Tumor Markers for Diagnosis Laboratory Examination
DOI:
https://doi.org/10.24293/ijcpml.v30i1.2114Keywords:
Ovarian cancer, HE4, CA-125, CEA, CA 19-9Abstract
Ovarian cancer is one of the gynecological malignancies with a bad outcome. Epidemiologically, it is the fifth cause of death in females worldwide. Patients have various complaints, and examinations available for early detection are inadequate, causing high mortality rates and late diagnosis. Prepare a more appropriate examination to establish an earlier diagnosis, especially in females with risk factors requiring screening. Laboratory examinations combined with other supporting examinations can provide better results to confirm the diagnosis of ovarian cancer and lower the morbidity rate. Knowing the updated examination to support the diagnosis, such as examination of ovarian cancer biological markers specific to HE4, CA-125, CEA, CA 19-9. A combination of examinations is needed for early detection of ovarian cancer.
Downloads
References
Pradjatmo H, Siswishanto R, Prawitasari S. Hubungan kadar CA-125 pra-operatif terhadap prognosis survival penderita kanker ovarium epitelial di RSUP Dr.Sardjito. J Kesehat Reproduksi, 2018; 5(1): 15.
Lin Y-H, Wu C-H, Fu H-C, Chen Y-J, Chen Y-Y, et al. Prognostic significance of elevated pretreatment serum CEA and CA-125 in epithelial ovarian cancer. Cancer Biomarkers, IOS Press, 2020; 28: 285–92.
Hapsari AV, Ambari E, Dewantiningrum J, Ushan EP. Karsinoma Ovarii Serosa pada kehamilan dengan komplikasi IUGR: Laporan kasus di RSUP Dr. Kariadi, Semarang. Medica Hosp J Clin Med, 2020; 7(1): 108–12.
Ionescu AM, Socea B, Dimitriu MCT, Constantin VD, Ionescu CA, et al. Struma Ovarii in a 56-year-old woman – A case report. Arch Balk Med Union, 2019; 54(2): 368–71.
Harzif AK, Pratama G, Maidarti M, Prameswari N, Shadrina A, et al. Ovarian cortex freezing as a method of fertility preservation in endometriosis: A case report. Ann Med Surg, 2022; 74.
Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G. Biomarkers and algorithms for the diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. Journal of Ovarian Research, 2019; 7: 1–9.
Silvana R. Tumor Krukenberg dengan metastasis signet ring cell pada ovarium. Syifa’ Med J Kedokt dan Kesehat, 2017; 7(2): 111.
Aqilla S, Harsono AB, Agustina H. Gambaran klinis dan histopatologi kanker ovarium di RSUP Dr. Hasan Sadikin Bandung Tahun 2019-2020. Indones J Obstet Gynecol Sci, 2022; 5(1): 127–35.
Nova Fenita Sari, Aswiyanti Asri HN. Sitomorfologi metastasis dysgerminoma pada bilasan peritoneum dengan konfirmasi histopatologi. 2022; 7: 7. Available from: https://jurnal.syntaxliterate.co.id/index.php/syntax-literate/article/view/8708/5022 (accessed Jan 23, 2023).
Aditiyono AA, Harsono AB, Susanto H. CA 125 dan risk of malignancy index (RMI) 2 sebagai prediktor keganasan tumor ovarium tipe epitel. Mandala Heal, 2018; 11(1): 18.
Cahyani KCD, Sriwidyani NP, Mahastuti NM, Saputra H. Karakteristik klinikopatologi pasien tumor ovarium pada anak tahun 2015–2019 di RSUP Sanglah Denpasar. E-Jurnal Med Udayana, 2022; 11(01): 67–71.
Dwi Ariningtyas N. CA 125 dan pemakaian klinis dalam penatalaksanaan kanker ovarium. Qanun Med - Med J Fac Med Muhammadiyah Surabaya, 2018; 2: 2.
Er OF, Kivrak H, Ozok O, Celik S, Kivrak A. A novel electrochemical sensor for monitoring ovarian cancer tumor protein CA 125 on benzothiophene derivative-based electrodes. J Electroanal Chem. 2022; 904.
Pradjatmo H, Siswishanto R, Prawitasari S. Hubungan kadar CA-125 pra-operatif terhadap prognosis survival penderita kanker ovarium epitelial di RSUP Dr.Sardjito. J Kesehat Reproduksi, 2018; 5(1): 15.
Lin Y-H, Wu C-H, Fu H-C, Chen Y-J, Chen Y-Y, et al. Prognostic significance of elevated pretreatment serum CEA and CA-125 in epithelial ovarian cancer. Cancer Biomarkers, IOS Press, 2020; 28: 285–92.
Hapsari AV, Ambari E, Dewantiningrum J, Ushan EP. Karsinoma Ovarii Serosa pada kehamilan dengan komplikasi IUGR: Laporan kasus di RSUP Dr. Kariadi, Semarang. Medica Hosp J Clin Med, 2020; 7(1): 108–12.
Ionescu AM, Socea B, Dimitriu MCT, Constantin VD, Ionescu CA, et al. Struma Ovarii in a 56-year-old woman – A case report. Arch Balk Med Union, 2019; 54(2): 368–71.
Harzif AK, Pratama G, Maidarti M, Prameswari N, Shadrina A, et al. Ovarian cortex freezing as a method of fertility preservation in endometriosis: A case report. Ann Med Surg, 2022; 74.
Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G. Biomarkers and algorithms for the diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. Journal of Ovarian Research, 2019; 7: 1–9.
Silvana R. Tumor Krukenberg dengan metastasis signet ring cell pada ovarium. Syifa’ Med J Kedokt dan Kesehat, 2017; 7(2): 111.
Aqilla S, Harsono AB, Agustina H. Gambaran klinis dan histopatologi kanker ovarium di RSUP Dr. Hasan Sadikin Bandung Tahun 2019-2020. Indones J Obstet Gynecol Sci, 2022; 5(1): 127–35.
Nova Fenita Sari, Aswiyanti Asri HN. Sitomorfologi metastasis dysgerminoma pada bilasan peritoneum dengan konfirmasi histopatologi. 2022; 7: 7. Available from: https://jurnal.syntaxliterate.co.id/index.php/syntax-literate/article/view/8708/5022 (accessed Jan 23, 2023).
Aditiyono AA, Harsono AB, Susanto H. CA 125 dan risk of malignancy index (RMI) 2 sebagai prediktor keganasan tumor ovarium tipe epitel. Mandala Heal, 2018; 11(1): 18.
Cahyani KCD, Sriwidyani NP, Mahastuti NM, Saputra H. Karakteristik klinikopatologi pasien tumor ovarium pada anak tahun 2015–2019 di RSUP Sanglah Denpasar. E-Jurnal Med Udayana, 2022; 11(01): 67–71.
Dwi Ariningtyas N. CA 125 dan pemakaian klinis dalam penatalaksanaan kanker ovarium. Qanun Med - Med J Fac Med Muhammadiyah Surabaya, 2018; 2: 2.
Er OF, Kivrak H, Ozok O, Çelik S, Kivrak A. A novel electrochemical sensor for monitoring ovarian cancer tumor protein CA 125 on benzothiophene derivative-based electrodes. J Electroanal Chem. 2022; 904.
Rachmad R, Andalas M, Yeni CM, Susanti ND, Kamarlis RK. Morphological index of Sassone for predicting serous type of epithelial ovarium cancer. Indones J Obstet Gynecol, 2020; 186–91.
Pan J, Hu Y, Sun S, Chen L, Schnaubelt M, et al. Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer. Nat Commun [Internet]. Springer US. 2020; (2020): 1–13. Available from: http://dx.doi.org/10.1038/s41467-020-19976-3 ((accessed Jan 23, 2023).
Petkova K, Chalkov V. The role of tumor markers CA 125, CA 72-4, and CA 19-9 in detecting and monitoring the course of disease of ovarian carcinoma and carcinoma of the uterine body. Strumica PHIMA, Macedonia N, 2019; 31: 931–6.
Aditiyono A, Budi Harsono A, Winarno GNA, Gandamihardja S, Kusumanto A, Susanto H. Pemeriksaan tunggal kadar osteopontin serum dan CA 125 untuk prediktor keganasan tumor ovarium tipe epitel: Inferior dibandingkan dengan pemeriksaan gabungan. Indones J Obstet Gynecol Sci, 2018; 1(1): 40–51.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
